NCT05279079View on ClinicalTrials.gov

Markers in Acute Pancreatitis-1

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 25, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

July 31, 2025

Conditions
Acute Pancreatitis Drug-Induced
Interventions
DIAGNOSTIC_TEST

Assessment of accuracy of microRNA and pancreatic enzyme markers in blood and/or urine in the detection and/or prediction of severity of drug-associated acute pancreatitis

Panel of microRNA and pancreatic enzyme biomarkers

Trial Locations (4)

29010

Hospital Regional Universitario de Málaga, Málaga

81377

LMU Klinikum München, Munich

L7 8XP

Royal Liverpool University Hospital, Liverpool

L9 7AL

Aintree University Hospital, Liverpool

All Listed Sponsors
collaborator

Innovative Medicines Initiative

OTHER

collaborator

TransBioLine Consortium

UNKNOWN

collaborator

Liverpool University Hospitals NHS Foundation Trust

OTHER_GOV

collaborator

Klinikum der Universität München

UNKNOWN

collaborator

Hospital Regional de Malaga

OTHER

lead

University of Liverpool

OTHER